Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Biomedical Materials Research

• Publication date

  1997-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-4636(19970615)35:4<525::AID-JBM12>3.0.CO;2-APMID 9189830
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osteoblast migration on poly(alpha-hydroxy esters).

  1996cited by this paper
• c-myc in vasculoproliferative disease.

  1995cited by this paper
• The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.

  1995cited by this paper
• Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*)

  1995cited by this paper
• Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery.

  1994cited by this paper
• Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique

  1994cited by this paper
• Contrasting Effects of the Intermittent and Continuous Administration of Heparin in Experimental Restenosis

  1994cited by this paper
• Transcatheter Delivery of c‐myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury

  1994cited by this paper
• Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

  1994cited by this paper
• Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty.

  1994cited by this paper
• Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

  1994cited by this paper
• Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Dissolution, Stability, and Morphological Properties of Conventional and Multiphase Poly(DL-Lactic-Co-Glycolic Acid) Microspheres Containing Water-Soluble Compounds

  1993cited by this paper
• Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.

  1993cited by this paper
• Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.

  1993cited by this paper
• Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.

  1992cited by this paper
• Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

  1992cited by this paper
• Induction of tenascin in rat arterial injury. Relationship to altered smooth muscle cell phenotype.

  1991cited by this paper
• Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres

  1991cited by this paper
• Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery.

  1990cited by this paper
• Restenosis after coronary angioplasty: new standards for clinical studies.

  1990cited by this paper
• Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury.

  1990cited by this paper
• Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. A new catheter approach.

  1987cited by this paper
• Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems

  1986cited by this paper
• Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.

  1986cited by this paper
• Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens

  1981cited by this paper
• Biodegradable polymers for use in surgery — poly(glycolic)/poly(Iactic acid) homo and copolymers: 2. In vitro degradation

  1981cited by this paper
• Antisense Oligonucleotides as Therapeutic Agents Is the Bullet Really Magical ?

  year unknowncited by this paper

• Glycoside scutellarin enhanced CD-MOF anchoring for laryngeal delivery

  2020cites this paper
• Polymer Particulates in Drug Delivery.

  2016cites this paper
• PLGA / PEG particles created by Nano-precipitation as drug delivery carriers for dipyridamole

  2016influential citation
• Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization.

  2016cites this paper
• Microdroplet chain array for cell migration assays.

  2016cites this paper
• Uveal Melanoma Metastasis Models

  2015cites this paper
• Modulation of Polyplex Release from Biodegradable Microparticles through Poly(ethylenimine) Modification and Varying Loading Concentration

  2013cites this paper
• Tenascins and inflammation in disorders of the nervous system

  2013cites this paper
• Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation.

  2013cites this paper
• Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation.

  2012cites this paper
• Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye.

  2011cites this paper
• Developing bone cement implants impregnated with bacteriocins for prevention of infections

  2011cites this paper
• Controlled Release of Anti-inflammatory siRNA from Biodegradable Polymeric Microparticles Intended for Intra-articular Delivery to the Temporomandibular Joint

  2011cites this paper
• The use of lipid microtubes as a novel slow‐release delivery system for laryngeal injection

  2011cites this paper
• Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies

  2010cites this paper
• Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: from fabrication to preclinical validation.

  2010cites this paper
• Effect of Polymer Molecular Weight on the Bone Biological Activity of Biodegradable Polymer/Calcium Phosphate Cement Composites

  2009cites this paper
• Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells

  2009cites this paper
• Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009cites this paper
• Nano and Microtechnologies for the Delivery of Oligonucleotides with Gene Silencing Properties

  2009cites this paper
• THEMED SECTION: VECTOR DESIGN AND DRUG DELIVERY REVIEW Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA

  2009cites this paper
• Current advances in research and clinical applications of PLGA-based nanotechnology

  2009cites this paper
• Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration.

  2008cites this paper
• 2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering.

  2008cites this paper
• Closing capacity of segmental radius defects in rabbits.

  2008cites this paper
• Quantitative morphological analysis of the neostriatum and the cerebellum of tenascin-C deficient mice

  2008influential citation
• Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration

  2008cites this paper
• The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats.

  2008cites this paper
• Does Sustained Epinephrine Release Trigger a Hypoxia-Neovascularization Cascade?

  2007cites this paper
• Can anti‐migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration

  2007cites this paper
• Polyethylenimine‐based antisense oligodeoxynucleotides of IL‐4 suppress the production of IL‐4 in a murine model of airway inflammation

  2006cites this paper
• Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells.

  2006cites this paper
• Porous Poly(DL-lactic-co-glycolic acid)/Calcium Phosphate Cement Composite for Reconstruction of Bone Defects

  2006influential citation
• Sustained Release of TGFβ3 from PLGA Microspheres and Its Effect on Early Osteogenic Differentiation of Human Mesenchymal Stem Cells

  2006cites this paper
• Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: potential of spray-drying technique

  2005cites this paper
• Cyclic mechanical strain‐induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs

  2005cites this paper
• Fetal oxygen tension promotes tenascin‐C–dependent lung branching morphogenesis

  2005cites this paper
• Biodegradable poly(terephthalate-co-phosphate)s: synthesis, characterization and drug-release properties

  2005cites this paper
• Engineered bone : growth factor loaded calcium phosphate cement matrices

  2005cites this paper
• SYNTHESIS OF NANOPARTICLES BY MICROEMULSION POLYMERIZATION AND THEIR APPLICATION IN A DRUG DELIVERY SYSTEM

  2005cites this paper
• Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo.

  2005cites this paper
• Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites.

  2005cites this paper
• Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain

  2005cites this paper
• Increased 5-HT2A receptor expression and function following central glucocorticoid receptor knockdown in vivo.

  2004cites this paper
• Gene therapy for restenosis--what now, what next?

  2004cites this paper
• Human microvascular endothelial cell growth and migration on biomimetic surfactant polymers.

  2004cites this paper
• Microsphere technology for chemotherapy of mycobacterial infections.

  2004cites this paper
• In-stent restenosis limitation with stent-based controlled-release nitric oxide: initial results in rabbits.

  2004cites this paper
• Study on biodegradable polymers: synthesis and characterization of poly(DL-lactic acid-co-L-lysine) random copolymer

  2003cites this paper
• rhBMP-2 Release from Injectable Poly(DL-Lactic-co-glycolic Acid)/Calcium-Phosphate Cement Composites

  2003cites this paper
• The potential of antisense as a CNS therapeutic

  2003cites this paper
• Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.

  2002cites this paper
• New research in breast reconstruction: adipose tissue engineering.

  2002cites this paper
• Altered hemodynamics controls matrix metalloproteinase activity and tenascin-C expression in neonatal pig lung.

  2002cites this paper
• Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.

  2002cites this paper
• Novel PDGFβR antisense encapsulated in polymeric nanospheres for the treatment of restenosis

  2002cites this paper
• Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites.

  2002cites this paper
• Effect of long‐term application of epinephrine on rat skin vasculature: Experimental study

  2002cites this paper
• Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

  2002cites this paper
• Scaffolds for Directing Cellular Responses and Tissue Formation

  2002cites this paper
• TGF-&bgr;1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function

  2001cites this paper
• Lipid-based microtubular drug delivery vehicles.

  2001cites this paper
• Telomerase - strategies to exploit an important chemotherapeutic target

  2001cites this paper
• Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides.

  2001cites this paper
• The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides

  2001cites this paper
• Synthetic Hydrogels as Carriers in Antisense Therapy: Preliminary Evaluation of an Oligodeoxynucleotide Covalent Conjugate with a Copolymer of 1-Vinyl-2-Pyrrolidinone and 2-Hydroxyethyl Methacrylate

  2001cites this paper
• Materials for Non-Viral Gene Delivery

  2001cites this paper
• HIGH-MOLECULAR WEIGHT POLYETHYLENE GLYCOLS CONJUGATED TO ANTISENSE

  2001cites this paper
• Drug delivery systems for the treatment of restenosis.

  2000cites this paper
• The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling

  2000cites this paper
• Site-Specific Administration of Antisense Oligonucleotides using Biodegradable Polymer Microspheres Provides Sustained Delivery and Improved Subcellular Biodistribution in the Neostriatum of the Rat Brain

  2000cites this paper
• Delivery systems for antisense oligonucleotides.

  2000cites this paper
• Controlled release of transforming growth factor β1 from biodegradable polymer microparticles

  2000cites this paper
• Augmentation of Adipofascial Flaps Using the Long-Term Local Delivery of Insulin and Insulin-Like Growth Factor-1

  2000cites this paper
• Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.

  2000cites this paper
• De Novo Adipose Tissue Generation through Long‐Term, Local Delivery of Insulin and Insulin‐Like Growth Factor‐1 by PLGA/PEG Microspheres in an in Vivo Rat Model: A Novel Concept and Capability

  2000cites this paper
• Increased Free Fat‐Graft Survival with the Long‐Term, Local Delivery of Insulin, InsulinLike Growth Factor‐I, and Basic Fibroblast Growth Factor by PLGA/PEG Microspheres

  2000cites this paper
• Chemistry of Antisense Oligonucleotides

  2000cites this paper
• Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.

  2000cites this paper
• Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.

  2000cites this paper
• Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique.

  2000cites this paper
• Enhanced Anti-Tumor Effects with Microencapsulated c-myc Antisense Oligonucleotide

  1999influential citation
• Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.

  1999cites this paper
• Biodegradable Microparticles for the Development of Less-Painful and Less-Irritating Parenterals

  1999cites this paper
• Microparticles of poly(dl-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery

  1997cites this paper